Wall Street Zen upgrades InnovAge stock to strong-buy
Alpha Vantage · ad-hoc-news.de · · AI-summarised by FinFlash
Wall Street Zen upgraded InnovAge (INNV) stock from buy to strong-buy on October 10, 2026. This upgrade came amidst cautious analyst sentiment, with a consensus target of USD 10.50. InnovAge reported fiscal 2026 revenue of USD 989.7 million and provided fiscal 2027 revenue guidance of USD 1.05 billion to USD 1.085 billion, with a market capitalization of USD 1.2 billion as of October 15, 2026.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.